Renal Cancer Diagnosis, Outlook, and Treatment Options

Renal cancer, also called kidney cancer, begins when abnormal cells grow in one or both kidneys. Many cases can be treated effectively, particularly when found early, and care is tailored to the tumor’s type, size, spread, kidney function, and the person’s general health.

Renal cancer at a glance

Renal cancer is a malignancy that starts in the kidneys, two organs located toward the back of the upper abdomen. The kidneys filter waste and excess fluid from blood, help regulate blood pressure, and support the production of red blood cells. In adults, the term renal cancer most often refers to renal cell carcinoma, which develops from cells in the kidney’s small filtering tubes.

Renal cancer is not a single disease. Its behavior and treatment can differ according to the cell type, whether the tumor is confined to the kidney, and a person’s health and kidney function. The most common subtype is clear cell renal cell carcinoma. Less common subtypes include papillary, chromophobe, collecting duct, and other rare forms. Childhood kidney cancers, such as Wilms tumor, are different conditions managed with pediatric oncology expertise.

Because small renal tumors often do not cause symptoms, they may be discovered incidentally during an ultrasound, CT scan, or MRI performed for another health concern. Finding a tumor early does not automatically mean it is aggressive; specialists use detailed imaging and other clinical information to decide on the safest, most appropriate next step.

Symptoms and signs that can occur

Early renal cancer commonly causes no noticeable symptoms. When symptoms do occur, they can be caused by many conditions other than cancer, including urinary stones, infections, or benign kidney problems. A medical assessment is important rather than trying to identify the cause based on symptoms alone.

Possible signs include blood in the urine, which may make urine appear pink, red, or brown; persistent pain or pressure in the side or lower back; and a lump in the side or abdomen. Some people experience unexplained weight loss, reduced appetite, fatigue, fever without an obvious infection, or anemia. These symptoms are not specific to renal cancer, but they should be discussed with a clinician when persistent or unexplained.

• Visible or repeated blood in the urine
• Persistent flank, side, or back discomfort
• A new abdominal or flank mass
• Ongoing fatigue, fever, or unexplained weight change
• Changes in general wellbeing that do not improve

More advanced disease can sometimes cause symptoms related to spread outside the kidney, such as persistent bone pain, shortness of breath, or neurological symptoms. These concerns need prompt medical evaluation, although they do not necessarily mean cancer is present.

Causes, risk factors, and inherited conditions

The exact cause of most renal cancers is not known. Cancer develops when changes in a cell’s genetic material allow it to grow and divide in an uncontrolled way. These changes are often acquired over time and are not usually inherited from a parent. Having a risk factor does not mean someone will develop renal cancer, and people without known risks can still be diagnosed.

Factors associated with a higher risk include tobacco use, excess body weight, high blood pressure, and long-term kidney disease. People who require long-term dialysis may also have an increased risk of certain kidney tumors. Occupational exposure to some substances may contribute in specific circumstances, although individual risk is difficult to determine without a full medical and work history.

A small proportion of renal cancers are linked with inherited genetic syndromes. These can include von Hippel-Lindau disease, hereditary leiomyomatosis and renal cell cancer, Birt-Hogg-Dubé syndrome, and hereditary papillary renal cell carcinoma. A doctor may recommend genetic counseling when renal cancer occurs at a younger age, affects both kidneys, involves multiple tumors, has an unusual subtype, or occurs alongside a strong family history.

How renal cancer is diagnosed and staged

Diagnosis usually begins with a medical history, physical examination, and imaging. Ultrasound can identify a kidney mass, while contrast-enhanced CT or MRI commonly provides more detailed information about its size, location, appearance, and possible involvement of nearby blood vessels or organs. Imaging also helps doctors look for signs that cancer may have spread.

Blood and urine tests do not diagnose renal cancer on their own, but they are valuable for checking kidney function, blood cell counts, liver function, and other health factors that may affect treatment planning. A chest scan and other tests may be used when clinically appropriate to assess for spread beyond the kidney.

A biopsy, in which a small tissue sample is taken with a needle, is helpful in selected situations. For example, it may be recommended before ablation, before systemic treatment for advanced disease, or when imaging cannot clearly distinguish a cancer from another type of kidney lesion. In some cases, especially when imaging strongly suggests a removable kidney cancer, the diagnosis can be confirmed after surgery.

Staging describes how far the cancer has grown or spread. Localized cancer is limited to the kidney or nearby tissues, while metastatic renal cancer has spread to distant parts of the body. Stage is important, but treatment decisions also consider tumor biology, symptoms, kidney reserve, other medical conditions, and personal preferences.

Modern treatment approaches

Treatment is individualized and often planned by a multidisciplinary team that may include urologists, medical oncologists, radiologists, pathologists, radiation oncologists, nephrologists, and specialist nurses. For a small tumor that appears slow-growing, particularly in an older person or someone with major health concerns, active surveillance may be appropriate. This means regular imaging and review, with treatment considered if the tumor changes or symptoms develop.

Surgery is a main treatment for many localized renal cancers. Whenever feasible, a partial nephrectomy removes the tumor while preserving the rest of the kidney. A radical nephrectomy removes the affected kidney and may be needed for larger or more complex tumors. Depending on the case, procedures may be performed using open, laparoscopic, or robot-assisted techniques. Robot-assisted kidney surgery may help some patients undergo a minimally invasive approach when it is clinically suitable.

For selected small tumors, thermal ablation can destroy cancer cells using heat or extreme cold, usually guided by imaging. This option may be considered when surgery carries higher risk or preserving kidney tissue is especially important. Cryoablation is one such approach and requires ongoing imaging follow-up because the treated area is monitored carefully over time.

For renal cancer that has spread or cannot be fully removed, systemic therapy may be recommended. Modern options include immunotherapy, targeted medicines that interfere with cancer growth signals, or combinations of these treatments. The choice depends on cancer subtype, pace of disease, previous treatment, overall health, and potential side effects. Radiation therapy is not usually used to cure a primary kidney tumor, but it can help control symptoms from cancer in specific areas, such as painful bone lesions or brain metastases.

Outlook, follow-up, and living with one kidney

The outlook for renal cancer varies considerably. It is influenced by stage, tumor subtype and grade, whether the cancer can be completely treated locally, response to systemic therapy when needed, and a person’s overall health. Localized tumors generally offer the broadest range of potentially curative treatment options. Even when cancer is advanced, newer systemic treatments can help control disease for some people, and care plans are reviewed over time.

After surgery, ablation, or systemic treatment, follow-up appointments commonly include imaging and blood tests at intervals decided by the care team. The schedule depends on the risk of recurrence and the type of treatment received. Follow-up also monitors kidney function, blood pressure, and treatment-related effects.

Many people live well with one functioning kidney or with reduced kidney tissue after partial nephrectomy. Protecting kidney health may include controlling blood pressure and diabetes, avoiding smoking, maintaining hydration as advised, and discussing potentially kidney-affecting medicines or supplements with a clinician. A balanced eating pattern and regular activity can support general wellbeing, but no diet or supplement has been proven to cure renal cancer.

Emotional support can be equally important. Patients may benefit from speaking with family, a cancer nurse, a counselor, or a support organization while navigating tests, treatment decisions, recovery, and long-term monitoring.

When to seek medical care

A person should arrange a medical appointment if they notice blood in the urine, persistent side or back pain, a new lump in the abdomen or flank, or ongoing unexplained fatigue, fever, appetite loss, or weight loss. These symptoms have many possible causes, but assessment is the safest way to identify the reason.

Urgent medical care is appropriate for heavy bleeding in the urine, inability to pass urine, severe pain, fainting, confusion, chest pain, or new severe shortness of breath. People with known kidney disease, a strong family history of renal cancer, or an inherited cancer syndrome should ask their clinician whether tailored screening or genetic counseling is appropriate.

For people diagnosed with renal cancer, discussing the case with a team experienced in kidney tumors can clarify the available options. Acıbadem Health Point’s multidisciplinary specialists and JCI-accredited hospitals evaluate and treat renal cancer for international patients, including surgical, interventional, and medical oncology care when needed.

Frequently asked questions